Concepts for Toxicokinetic-Toxicodynamic Modelling in Clinical Toxicology: Application to Acute Cardiac Glycoside Intoxications

  • M. Urtizberea
  • A. Sabouraud
  • F. Baud
  • M. Rochdi
  • M. Debray
  • C. Bismuth
  • J. M. Scherrmann
Part of the Archives of Toxicology book series (TOXICOLOGY, volume 15)

Abstract

Relationships between pharmacokinetics (PK) and pharmacodynamics (PD) are now widely investigated for many drugs with the aim of improving the amount and the rate of drug delivery so as to control the duration and intensity of the pharmacological effect (Levy 1966; Holford 1981). Such relationships have not yet been investigated for toxic effects of drugs as occurs after acute self-poisoning. The establishment of relationships between kinetics of drugs at toxic doses (Toxicokinetics) and those of their pharmacological effects (Toxicodynamics) can be of interest in clinical toxicology. The aim would be to predict the occurrence and the intensity of toxic effects as a function of the ingested dose and the first plasma concentrations on admission of the patient to improve management. In this paper, we describe the different techniques of kinetic-effect modelling actually available, their applications in the case of acute digitalis poisoning and the limits of such techniques in clinical toxicology.

Keywords

Bismuth Glycoside Digoxin Theophylline Toxicology 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bismuth C, Gautier M, Conso P (1973) Hyperkaliemia in acute digitalis poisoning: prognostic, significance and therapeutic implications. Clin Toxicol 6: 153–162PubMedCrossRefGoogle Scholar
  2. Grevel J (1987) Kinetic-effect models and their applications. Pharm Res 4: 86–92PubMedCrossRefGoogle Scholar
  3. Hamlyn JM (1989) Increased levels of a humoral digitalis-like factors in deoxycorticosterone acetate induced hypertension in the pig. J Endocrinol 122: 165–166CrossRefGoogle Scholar
  4. Henion WA, Montodo A, Hilala A, Bayer R, Cohen J (1983) Changes in red blood cells electrolytes concentrations in digitalis intoxication. 106: 14–20Google Scholar
  5. Holford NHG, Sheiner LB (1981) Understanding the dose effect relationship: clinical application of pharmacocinetic-pharmacodynamic models. Clin Pharmacokin 6: 14–20CrossRefGoogle Scholar
  6. Kelman AW, Whiting B (1980) Modeling of drug response in individual subjects. J Pharmacokin Biopharm 7: 47–61Google Scholar
  7. Kramer WG, Kolisbash AJ, Lewis RP, Bathala MS, Visconti J, Reuning RH (1979) Pharmacokinetics of digoxin relationship between response intensity and predicted compartment drug levels in man. J Pharmacokin Biopharm 7: 47–61CrossRefGoogle Scholar
  8. Levy G (1966) Kinetics of pharmacologic effects. Clin Pharmacol Ther 7: 462–472Google Scholar
  9. Loes MW, Singh S, Lock JE, Birkin M (1978) Relation between plasma and red-cell electrolyte concentration and digoxin levels in children. N Eng J Med 299: 501–504CrossRefGoogle Scholar
  10. Nielsen-Kudsk JE, Askholt J (1988) Pharmacokinetics of enprofylline and theophylline in the isolated rabbit heart. Pharmacol Toxicol 63: 193–188CrossRefGoogle Scholar
  11. Ochs H, Grube E, Greenblat DJ, Arendt R, Bodem G (1981) Pharmacokinetics and pharmacodynamics of intravenous digoxin and digitoxin. Klin Wschr 59: 889–897PubMedCrossRefGoogle Scholar
  12. Shapiro W, Natahara K, Taubert K (1970) Relationship of plasma digitoxin and digoxin to cardiac response following intravenous digitalization in man. Circulation 49: 1065–1072Google Scholar
  13. Sheiner LB, Stanski DR, Vozeh S, Ham J (1979) Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther 29: 358–371Google Scholar
  14. Urtizberea M, Rochdi M, Baud FJ, Scherrmann JM (1990) Toxicokinetic-toxicodynamic models describing the relation of plasma and red blood cells potassium with plasma digitalis acute in acute human digitalis poisoning. Tox in Vitro 4: 526–531CrossRefGoogle Scholar
  15. Urtizberea M, Rochdi M, Sabouraud A, Bismuth C, Scherrmann JM (1991) Relationship between red blood cell potassium and plasma digitoxin concentrations in intoxicated patients. Pharmacol Toxicol 68: 237–242PubMedCrossRefGoogle Scholar
  16. Vetticaden SJ, Barr WH, Allison TB (1989) Pharmacodynamic modeling of digoxin induced bradycardia. J Pharmacokin Biopharm 17: 89–107CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • M. Urtizberea
    • 1
  • A. Sabouraud
    • 1
  • F. Baud
    • 2
  • M. Rochdi
    • 1
  • M. Debray
    • 3
  • C. Bismuth
    • 2
  • J. M. Scherrmann
    • 1
  1. 1.INSERM U.26 Hôpital Fernand WidalParisFrance
  2. 2.Clinique ToxicologiqueHôpital Fernand WidalFrance
  3. 3.Faculté de PharmacieParisFrance

Personalised recommendations